Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome

International Journal of Molecular Medicine

Volumn 21, Issue 6, 2008, Pages 801-808

  Yamada, Yoshiji ^a   Kato, Kimihiko ^b   Oguri, Mitsutoshi ^b   Yoshida, Tetsuro ^b   Yokoi, Kiyoshi ^b   Watanabe, Sachiro ^c   Metoki, Norifumi ^d   Yoshida, Hidemi ^e   Satoh, Kei ^e   Ichihara, Sahoko ^a   Aoyagi, Yukitoshi ^f   Yasunaga, Akitomo ^f   Park, Hyuntae ^f   Tanaka, Masashi ^f   Nozawa, Yoshinori ^g  

^a MIE UNIVERSITY   (Japan)

^b GIFU PREFECTURAL TAJIMI HOSPITAL   (Japan)

^c GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^d Hirosaki Stroke Center   (Japan)

^e HIROSAKI UNIVERSITY   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^g GIFU INTERNATIONAL INSTITUTE OF BIOTECHNOLOGY   (Japan)

Author keywords

Atherothrombotic cerebral infarction; Genetics; Ischemic stroke; Metabolic syndrome; Polymorphism

Indexed keywords

ADENOSINE; ADIPONECTIN; ALANINE; ASPARAGINE; ASPARTIC ACID; CYTOSINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 1; FATTY ACID BINDING PROTEIN 2; GENE PRODUCT; GUANOSINE; PROTEIN ALOX5AP; PROTEIN IPF1; PROTEIN LGALS2; PROTEIN ROS1; PROTEIN TYROSINE KINASE; THREONINE; UNCLASSIFIED DRUG; 5-LIPOXYGENASE-ACTIVATING PROTEIN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CARRIER PROTEIN; FABP1 PROTEIN, HUMAN; FABP2 PROTEIN, HUMAN; GALECTIN 2; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; LGALS2 PROTEIN, HUMAN; MEMBRANE PROTEIN; NOS3 PROTEIN, HUMAN; ONCOPROTEIN; ROS1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

AGE; AGED; ARTICLE; BODY MASS; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENDER; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPANESE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OCCLUSIVE CEREBROVASCULAR DISEASE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ASIAN; CHI SQUARE DISTRIBUTION; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; JAPAN; MIDDLE AGED; STATISTICAL MODEL;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARRIER PROTEINS; CEREBRAL INFARCTION; CHI-SQUARE DISTRIBUTION; FATTY ACID-BINDING PROTEINS; FEMALE; GALECTIN 2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; JAPAN; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; PREVALENCE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RISK FACTORS; TRANS-ACTIVATORS; VARIATION (GENETICS);

EID: 47649096529     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.21.6.801     Document Type: Article

References (30)

1. Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752, 2005.
2. Lakka HM, Laaksonen DE, Lakka TA, et al: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002.
3. McNeill AM, Rosamond WD, Girman CJ, et al: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care 28: 385-390, 2005.
4. Boden-Albala B, Sacco RL, Lee HS, et al: Metabolic syndrome and ischemic stroke risk. Northern Manhattan Study. Stroke 39: 30-35, 2008
5. Chen HJ, Bai CH, Yeh WT, Chiu HC and Pan WH: Influence of metabolic syndrome and general obesity on the risk of ischemic stroke. Stroke 37: 1060-1064, 2006.
6. Iso H, Sato S, Kitamura A, et al: Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women. Stroke 38: 1744-1751, 2007.
7. Kurl S, Laukkanen JA, Niskanen L, et al: Metabolic syndrome and the risk of stroke in middle-aged men. Stroke 37: 806-811, 2006.
8. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D'Agostino RB and Wolf PA: Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 166: 106-111, 2006.
9. Warlow C, Sudlow C, Dennis M, Wardlaw J and Sandercock P: Stroke. Lancet 362: 1211-1224, 2003.
10. Sattar N, Gaw A, Scherbakova O, et al: Metabolic syndrome with and without C-protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108: 414-419, 2003.
11. Ridker PM, Buring JE, Cook NR and Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107: 391-397, 2003.
12. Kanazawa M, Yoshiike N, Osaka T, Numba Y, Zimmet P and Inoue S: Criteria and classification of obesity in Japan and Asia-Oceania. Asia Pac J Clin Nutr 11: S732-S737, 2002.
13. A committee established by the Director of the National Institute of Neurological Disorders and Stroke, National Institutes of Health: Special report from the National Institute of Neurological Disorders and Stroke. Classification of Cerebrovascular Diseases III. Stroke 21: 637-676, 1990.
14. Yamada Y, Metoki N, Yoshida H, et al: Genetic risk for ischemic and hemorrhagic stroke. Arterioscler Thromb Vasc Biol 26:1920-1925, 2006.
15. Yamada Y, Metoki N, Yoshida H, et al: Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals. Stroke (In press).
16. Itoh Y, Mizuki N, Shimada T, et al: High throughput DNA typing of HLA-A, -B, -C and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 57: 717-729, 2005.
17. Lowe JB, Sacchettini JC, Laposata M, McQuillan JJ and Gordon JI: Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J Biol Chem 262: 5931-5937, 1987.
18. Baier LJ, Sacchettini JC, Knowler WC, et al: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95: 1281-1287, 1995.
19. Yamada K, Yuan X, Ishiyama S, et al: Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men. Diabetologia 40: 706-710, 1997.
20. Galluzzi JR, Cupples LA, Otvos JD, Wilson PW, Schaefer EJ and Ordovas JM: Association of the A/T54 polymorphism in the intestinal fatty acid binding protein with variations in plasma lipids in the Framingham Offspring Study. Atherosclerosis 159: 417-424, 2001.
21. Guettier JM, Georgopoulos A, Tsai MY, et al: Polymorphisms in the fatty acid-binding protein 2 and apolipoprotein C-III genes are associated with the metabolic syndrome and dyslipidemia in a South Indian population. J Clin Endocrinol Metab 90: 1705-1711, 2005.
22. Carlsson M, Orho-Melander O, Hedenbro J, Alingren P and Groop LC: The T54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke. J Clin Endocrinol Metab 85: 2801-2804, 2000.
23. Georgopoulos A, Bloomfield H, Collins D, et al: Codon 54 polymorphism of the fatty acid binding protein (FABP) 2 gene is associated with increased cardiovascular risk in the dyslipidemic diabetic participants of the Veterans Affairs HDL intervention trial (VA-HIT). Atherosclerosis 194: 169-174, 2007.
24. Helgadottir A, Manolescu. A, Thorleifsson G, et al: The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36: 233-239, 2004.
25. Howard TD, Giles WH, Xu J, et al: Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women. Stroke 36: 1848-1851, 2005.
26. Yamada Y, Matsuo H, Segawa T, et al: Assessment of genetic risk for myocardial infarction. Thromb Haemost 96: 220-227, 2006.
27. Shiffman D, Ellis SG, Rowland CM, et al: Identification of four gene variants associated with myocardial infarction. Am J Hum Genet 77: 596-605, 2005.
28. Nishihama K, Yamada Y, Matsuo H, et al: Genetic risk for myocardial infarction stratified by sex or the presence or absence of conventional risk factors. Int J Mol Med 19: 129-141, 2007.
29. Yoshida T, Yajima K, Hibino T, et al: Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles. Int J Mol Med 20: 581-590, 2007.
30. Ozaki K, Inoue K, Sato H, et al: Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 429: 72-75, 2004.